There is currently an intensified commitment toward advancing scientific understanding of Cognitive Impairment Associated with Schizophrenia (CIAS). Researchers are directing significant efforts toward developing innovative neuropsychiatric drugs. This commitment originates from a recognition of the critical influence exerted by cognitive impairment on the overall quality of life for individuals afflicted...
Discover more insights